ADAR1 Capital Management »

Connect Biopharma Hldgs shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Connect Biopharma Hldgs (CNTB) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Connect Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Connect Biopharma Hldgs held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Connect Biopharma Hldgs by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 742k 2.62

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Connect Biopharma Hldgs

Ikarian Capital
Boothbay Fund Management
683 Capital Management
Perceptive Advisors
ADAR1 Capital Management
Richmond Brothers
Millennium Management
BML Capital Management
Knott David M Jr
Susquehanna International
Stonepine Capital Management
Propel Bio Management
Diadema Partners
Burkehill Global Management
Renaissance Technologies

View all funds holding Connect Biopharma Hldgs